Clinical Trials · NCT07881770
Semaglutide Health Outcomes and Patient Adherence in Australia
- Phase
- N/A
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 10,000
- Start date
- Oct 2026
- Locations
- 1 site, Australia
- Primary endpoint
- Absolute change in body weight from baseline